In this study, we confirmed the relationship between ISL1-S629-p expression and the overall survival time of patients with GC (35 poorly differentiated adenocarcinoma, 22 moderately differentiated adenocarcinoma, 3 well-differentiated adenocarcinoma) (Fig. 3e). This evidence concerns the gene ISL1 and adenocarcinoma.